Navigation Links
Gamida Cell Announces $4.4 Million Grant from the Israeli Government
Date:5/23/2016

JERUSALEM, May 23, 2016 /PRNewswire/ --

Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today it has been awarded a grant of up to $4.4 million from the Israel Innovation Authority (formerly the Office of the Chief Scientist) of the Israeli Ministry of Economy and Industry. The mission of the Israel Innovation Authority is to encourage innovation and entrepreneurship in various industries, including science and technology, while stimulating economic growth.

The non-dilutive funding will support Gamida Cell's ongoing research and development efforts including its Phase 3 registration study of NiCord® for hematological malignancies (blood cancers like leukemia and lymphoma), and its clinical trials of CordIn® for sickle cell disease and thalassemia and NK cells as a potential immune therapy for cancer.

"We are very pleased to have received this grant and know it will contribute to our broad clinical development plans for this year, which include the launch of a registration study for our lead program and early clinical stage work on our immuno-oncology candidate. The grant announced today is the largest amount we have been rewarded to date. We feel it is a clear demonstration of the Innovation Authority's ongoing confidence and trust in our important mission," said Dr. Yael Margolin, Gamida Cell's president and CEO.

About Gamida Cell  

Gamida Cell is a world leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases. The company's pipeline of products are in development to treat a wide range of conditions including cancer, genetic hematological diseases such as sickle cell disease and thalassemia, bone marrow failure syndromes such as aplastic anemia, genetic metabolic diseases and refractory autoimmune diseases. Gamida Cell's current shareholders include: Novartis, Elbit Imaging, Clal Biotechnology Industries, Israel Healthcare Venture, Teva Pharmaceutical Industries, Denali Ventures and Auriga Ventures.   For more information please visit http://www.gamida-cell.com.

Press Contact:
Marjie Hadad
MH Communications
+972-54-536-5220
marjierhadad@gmail.com

Investor Contact:
Beth DelGiacco
Stern Investor Relations, Inc.
+1-212-362-1200
beth@sternir.com


'/>"/>
SOURCE Gamida Cell
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
2. Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
3. Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
4. Purdue Pharma Announces Patent Agreement with Egalet and Acura
5. DS Biopharma Announces DS102 will be Developed for Pulmonary Disorders in Addition to NASH
6. Mauna Kea Technologies Announces Strong Presence of Cellvizio Platform at Major Medical Meetings Focused on Gastroenterology
7. Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Associations 21st Congress
8. Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study
9. Lightpoint Medical Announces Exclusive Global License Agreement With the University of Arizona to Develop Molecular Imaging Technology
10. New Colombia Resources Sannabis Subsidiary Announces Filing for Medical Marijuana Licenses With the Ministry of Justice in order to Export Products
11. Aptuit Announces Acquisition of Kuecept Ltd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... October 08, 2019 , ... Villa Healthcare, a leader ... why they chose to work at Villa and what their work means to them. ... Berger and CFO Steve Nagel prepared the giant checks. Anticipation was high as ...
(Date:10/8/2019)... ... , ... Four things to know: , 1. The Hive™ ALIF interbody contains ... the lattice core. , 2. The Soft Titanium® lattice of HD LifeSciences ... growth throughout the implant. , 3. The Hive™ ALIF device can hold over 5cc ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Dorette Noorhasan ... Miracle Baby: A Fertility Doctor’s Fight for Motherhood (Brown Books Publishing Group), which ... writes to educate, encourage, advise and support people who want to bring a ...
Breaking Medicine Technology:
(Date:10/8/2019)... , ... October 08, 2019 , ... ... acquired a majority interest in Advanced Fertility Care (AFC), an advanced reproductive services ... forces to expand the availability of RE services to expectant families throughout Arizona ...
(Date:10/8/2019)... ... October 08, 2019 , ... Drs. Joel Rosenlicht ... with missing teeth restore their smiles with long-lasting dental implants . Placing ... advanced i-CAT® 3D Cone Beam CT imaging, X-Guide™ software and Yomi® robotic-assisted technology ...
(Date:10/8/2019)... ... , ... Over the past three decades, Buffalo Wings & Rings has elevated ... by providing a higher-quality product and experience than the competition. Now, the club-level sports ... A MUG FOR THE CAUSE" campaign in support of Breast Cancer Awareness Month. ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... Smile Brands ... culture and compensation monitoring site, Comparably. Smile Brands, a leading dental support organization with ... the company’s mission to deliver Smiles for Everyone®. The Happiness Award is the latest ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. ... has recently attended an advanced Level III training in Cagliari, Italy, this past ... training took place September 16-19, 2019 at the Sardinia Dental Teaching Center and ...
Breaking Medicine News(10 mins):